RASL11B and renal cell carcinoma: MEG3 up-regulates RASL11B expression by binding to, competing with and suppressing miR-7, leading to reduction in RCC cell proliferation, migration and invasion, and induction in RCC cell cycle arrest and apoptosis [10] (Table 2).